Table 1.

Effect of sin-1 Plus Anti–HLA-DR MoAb H81.9 on CFU-GM Production in Canine and Human LTMCS

LTMC (wk of CFU-GM Assay)Culture Conditions
ControlH81.9*H81.9* + Sin-1 (1 μg/mL)H81.9* + Sin-1 (100 μg/mL)
(A)Canine 
100 24 ± 8 ND 12 ± 6 
100 13 ± 7 ND 11 ± 7 
100 45 ± 5 ND 21 ± 9 
100 30 ± 6 ND 17 ± 7 
    (B)Human 
100 32 ± 4 51 ± 5 18 ± 3 
100 10 ± 7 21 ± 6 1 ± 1 
100 2 ± 4 20 ± 3 1 ± 1 
100 0 ± 1 18 ± 4 0 ± 1 
LTMC (wk of CFU-GM Assay)Culture Conditions
ControlH81.9*H81.9* + Sin-1 (1 μg/mL)H81.9* + Sin-1 (100 μg/mL)
(A)Canine 
100 24 ± 8 ND 12 ± 6 
100 13 ± 7 ND 11 ± 7 
100 45 ± 5 ND 21 ± 9 
100 30 ± 6 ND 17 ± 7 
    (B)Human 
100 32 ± 4 51 ± 5 18 ± 3 
100 10 ± 7 21 ± 6 1 ± 1 
100 2 ± 4 20 ± 3 1 ± 1 
100 0 ± 1 18 ± 4 0 ± 1 

Results summarize data from two experiments each for canine and human cells. At each timepoint CFU-GM assays were set up in triplicate. Results are expressed as percent of control. Colony numbers in canine control cultures were 123 ± 14, 81 ± 12, 79 ± 15, and 62 ± 18, and in human cultures 240 ± 28, 215 ± 30, 180 ± 27, and 160 ± 36 at 1, 2, 3, and 4 weeks, respectively.

Abbreviation: ND, not done.

*

10 μg/mL in all assays.

or Create an Account

Close Modal
Close Modal